TCS
Texas Children's Portfolio holdings
AUM $20.5M
1-Year Return
51.2%
This Quarter Return
+14.68%
1 Year Return
-51.2%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$82.2M
AUM Growth
+$10.5M
(+15%)
Cap. Flow
+$6.19M
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
87.85%
Holding
45
New
4
Increased
8
Reduced
9
Closed
21
Top Buys
| 1 |
Enterprise Products Partners
EPD
|
+$7.45M |
| 2 |
Solid Biosciences
SLDB
|
+$1.14M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$808K |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$612K |
| 5 |
AMRN
Amarin Corp
AMRN
|
+$585K |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$1.1M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
+$915K |
| 3 |
Incyte
INCY
|
+$690K |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$533K |
| 5 |
Merus
MRUS
|
+$523K |
Sector Composition
| 1 | Energy | 57.74% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Staples | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Black Stone Minerals
BSM
$2.72B
| $40M | 48.66% |
2,268,592
| – | – |
|
2
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.8B
| $14.8M | 18.04% |
120,651
| – | – |
|
|
3
Enterprise Products Partners
EPD
$68.8B
| $7.46M | 9.08% |
256,470
+256,189
| +91,170% | +$7.45M |
|
4
VanEck Oil Services ETF
OIH
$976M
| $2.34M | 2.84% |
6,779
| – | – |
|
|
5
Solid Biosciences
SLDB
$421M
| $1.3M | 1.57% |
9,382
+8,279
| +751% | +$1.14M |
|
6
Wave Life Sciences
WVE
$1.09B
| $1.19M | 1.44% |
30,546
+13,267
| +77% | +$516K |
|
7
United Therapeutics
UTHR
$18B
| $1.1M | 1.34% |
9,397
+3,711
| +65% | +$436K |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36B
| $1.1M | 1.33% |
8,306
+624
| +8% | +$82.3K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $999K | 1.21% |
7,389
-1,787
| -19% | -$242K |
|
|
ABMD
10
DELISTED
Abiomed Inc
ABMD
| $905K | 1.1% |
3,169
-477
| -13% | -$136K |
|
|
GHDX
11
DELISTED
Genomic Health, Inc.
GHDX
| $838K | 1.02% |
11,967
+3,932
| +49% | +$275K |
|
12
BioMarin Pharmaceuticals
BMRN
$10.4B
| $817K | 0.99% |
9,202
+155
| +2% | +$13.8K |
|
|
CCXI
13
DELISTED
ChemoCentryx, Inc.
CCXI
| $808K | 0.98% |
+58,142
| New | +$808K |
|
|
14
Incyte
INCY
$16.4B
| $785K | 0.95% |
9,125
-8,017
| -47% | -$690K |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $774K | 0.94% |
10,566
-2,581
| -20% | -$189K |
|
16
Neurocrine Biosciences
NBIX
$14B
| $741K | 0.9% |
8,409
+1,971
| +31% | +$174K |
|
|
ZGNX
17
DELISTED
Zogenix, Inc.
ZGNX
| $739K | 0.9% |
13,429
-1,322
| -9% | -$72.8K |
|
|
18
Acadia Pharmaceuticals
ACAD
$4.04B
| $657K | 0.8% |
24,471
-34,075
| -58% | -$915K |
|
|
ARRY
19
DELISTED
Array Biopharma Inc
ARRY
| $621K | 0.76% |
25,485
-44,950
| -64% | -$1.1M |
|
20
Amicus Therapeutics
FOLD
$2.47B
| $620K | 0.75% |
45,589
-11,953
| -21% | -$163K |
|
|
21
Iovance Biotherapeutics
IOVA
$832M
| $612K | 0.74% |
+64,348
| New | +$612K |
|
|
AMRN
22
Amarin Corp
AMRN
$309M
| $585K | 0.71% |
+1,410
| New | +$585K |
|
23
BioCryst Pharmaceuticals
BCRX
$1.63B
| $492K | 0.6% |
+60,479
| New | +$492K |
|
24
EOG Resources
EOG
$66B
| – | – |
-120
| Closed | -$10K |
|
25
General Dynamics
GD
$87.8B
| – | – |
-198
| Closed | -$31K |
|